Previous 10 | Next 10 |
2023-12-12 19:21:37 ET Summary Celestica's stock initially dipped after its third quarter earnings report in October, but the "Strong Buy" quant score prevailed and shares rebounded. Stock rating among its peer comparisons reviewed. The company's strong Q3 results, including i...
2023-12-08 16:53:34 ET Summary Journey Medical shows a meteoric rise, led by strategic focus on dermatology and product innovation. Despite challenges, DFD-29, an oral treatment for rosacea, shows promise, potentially revolutionizing moderate to severe cases. Q3 2023 financial...
SCOTTSDALE, Ariz., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (...
2023-11-29 13:02:14 ET More on mid-day movers stocks. Sonder Holdings Inc. (SOND) Q3 2023 Earnings Call Transcript Fusion Fuel receives purchase order from Portuguese energy company for 1.25 MW electrolyzer facility Fusion Fuel Green receives Nasdaq notice regarding ...
2023-11-15 11:44:02 ET More on Markets UBS highlights 14 stocks on its list of high-conviction names Global X says AI, cybersecurity among four key themes for 2024 Cathie Wood's ARK Invest launches crypto ETFs in partnership with 21Shares Producer Price Index...
2023-11-12 00:34:07 ET Journey Medical Corporation (DERM) Q3 2023 Earnings Conference Call November 7, 2023, 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founder, President and CEO Joseph Benesch - Inter...
2023-11-07 17:31:24 ET More on Journey Medical Journey Medical Corporation (DERM) Q2 2023 Earnings Call Transcript Journey Medical director Paley buys 15k shares - filing Journey Medical announces exclusive license agreement with Maruho Seeking Alpha’s...
Company generated total net revenues of $34.5 million in the third quarter of 2023, a 101% increase from $17.2 million in the second quarter of 2023 GAAP net income increased to $16.8 million, or $0.91 per share bas...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Journey Medical Corporation (DERM) is expected to report $-0.16 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Journey Medical Corporation Company Name:
DERM Stock Symbol:
NASDAQ Market:
Journey Medical Corporation Website:
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial...
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (...
New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a 7% increase from the $12.2 million reported in the...